Mesley Mallari

Wuhan Co-Walking Laser Tech is a manufacturer of high power CO2 fiber laser with applications in food machinery, textile cutting, automobile manufacturing, 3D printing, architecture, shipbuilding and aerospace.

Wonder Workshop is a San Mateo based company founded by Vikas Gupta curating physical coding and applied robotics programs for children. The company created the first products, Dash & Dot, in September 2013.

DroneTerminus is a Boca Raton based company founded by Joe McMillian, Mark Messina, Paul Caprioli. The company manufactures hardware and technology for autonomous drone technologies, Unmanned Aerial Systems (UAS), Unmanned Aerial Vehicles (UAV), fleet management, autonomous drones, and drone infrastructure.

Agena Bioscience was formed in 2014 when venture capital firm, Telegraph Hill Partners, acquired the Bioscience Department of Sequenom, a developer and manufacturer for the molecular diagnostic market. 

Agena Bioscience is pioneering precision medicine with its cost-effective mass spectrometry machine that has an abundance of applications in fields such as SNP genotyping, gene expression research, liquid biopsies for tumor profiling and methylation of DNA. 

When initiating treatment, healthcare providers factor in dosages, patient weight, age and even gender when prescribing the standard dosage. Clinically, however, individuals respond differently to active pharmaceutical ingredients and this is where genotyping can augment patient care. Pharmacogenetics investigates the influence of a single gene on dosing efficacy and toxicities. Analyzing genes provides an accurate pathway to optimize drug therapy and medicine metabolization.

Genetic, environmental, and developmental factors that can interact, causing variations in drug response among patients

DNA is extracted from a self-collected buccal swab which produces takes a detailed profiling of 20 different gene variants that play a factor in drug metabolism. 

List of gene variations detected by the MassArray VeriDose Core Panel

Liquid Biopsy is a less-invasive alternative to surgical biopsies which enables physicians to obtain further information on a tumor’s progression, by drawing 5mL of a patient’s blood. While liquid biopsies have the potential to revolutionize cancer diagnosing, it is best used alongside tissue samples. 

The genomic information retrieved determines disease progression and treatment resistance best used in molecular oncology and hematopathology.